Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
innovative dermatology drug development
- B2B
About Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Developing and commercializing innovative dermatology products targeting inflammation and immunology to address unmet medical needs efficiently and effectively.
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Westlake Village, California, United States
- Founded
- 2016
- Revenue
- $376MFY2025, publicly reported
- Website
- arcutis.com
- linkedin.com/company/arcutis-inc
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) at a glance
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a B2B company in the Biotechnology Research industry, headquartered in Westlake Village, California, United States.
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) was founded in 2016.
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has 251–1,000 employees.
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s revenue is $376M (FY2025, publicly reported).
Selling to companies like Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies